Skip to menu Skip to content Skip to footer
Dr

Megan France

Email: 

Overview

Availability

Dr Megan France is:
Available for supervision

Works

Search Professor Megan France’s works on UQ eSpace

4 works between 2010 and 2021

1 - 4 of 4 works

2021

Journal Article

Outcomes of artery embolisation for cystic fibrosis patients with haemoptysis: a 20-year experience at a major Australian tertiary centre

Semasinghe Bandaralage, Sahan P., Tay, George, Hay, Karen, Megram, Emma, Smith, Daniel, Gadowski, Tahlia, Wright, Eimear, France, Megan, Bell, Scott and Reid, David (2021). Outcomes of artery embolisation for cystic fibrosis patients with haemoptysis: a 20-year experience at a major Australian tertiary centre. Internal Medicine Journal, 51 (9), 1526-1529. doi: 10.1111/imj.15483

Outcomes of artery embolisation for cystic fibrosis patients with haemoptysis: a 20-year experience at a major Australian tertiary centre

2019

Journal Article

Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung disease

Tong, Koliarne, Barker, Daniel, France, Megan, Burr, Lucy, Greville, Hugh, Visser, Simone, Middleton, Peter, Wainwright, Claire, Dorahy, Douglas and Wark, Peter (2019). Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung disease. Journal of Cystic Fibrosis, 19 (3), 415-420. doi: 10.1016/j.jcf.2019.12.006

Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung disease

2013

Journal Article

Ivacaftor in severe cystic fibrosis lung disease and a G551D mutation

Wood, Michelle E., Smith, Daniel J., Reid, David W., Masel, Philip J., France, Megan W. and Bell, Scott C. (2013). Ivacaftor in severe cystic fibrosis lung disease and a G551D mutation. Respirology Case Reports, 1 (2), 52-54. doi: 10.1002/rcr2.27

Ivacaftor in severe cystic fibrosis lung disease and a G551D mutation

2010

Conference Publication

Antibiotic desensitisation in cystic fibrosis patients with a history of hypersensitivity undergoing lung transplantation is not mandatory

Tse, T., Hopkins, P. M. A., France, M. W., Masel, P. J., Bell, S. C., Kermeen, F. D. and Chambers, D. C. (2010). Antibiotic desensitisation in cystic fibrosis patients with a history of hypersensitivity undergoing lung transplantation is not mandatory. 30th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation, Chicago Il, Apr 21-24, 2010. ELSEVIER SCIENCE INC.

Antibiotic desensitisation in cystic fibrosis patients with a history of hypersensitivity undergoing lung transplantation is not mandatory

Supervision

Availability

Dr Megan France is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Media

Enquiries

For media enquiries about Dr Megan France's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au